Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
11.32
+1.04 (10.12%)
At close: Mar 31, 2026, 4:00 PM EDT
11.10
-0.22 (-1.94%)
After-hours: Mar 31, 2026, 7:58 PM EDT
Korro Bio Market Cap
Korro Bio has a market cap or net worth of $163.26 million as of March 31, 2026. Its market cap has decreased by -29.24% in one year.
Market Cap
163.26M
Enterprise Value
121.56M
1-Year Change
-29.24%
Ranking
Category
Stock Price
$11.32
Market Cap Chart
Since November 6, 2023, Korro Bio's market cap has increased from $123.80M to $163.26M, an increase of 31.88%. That is a compound annual growth rate of 12.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 148.26M | 96.55% |
| Dec 31, 2025 | 75.43M | -78.85% |
| Dec 31, 2024 | 356.65M | -6.96% |
| Dec 29, 2023 | 383.31M | 209.63% |
| Nov 6, 2023 | 123.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cartesian Therapeutics | 155.87M |
| Whitehawk Therapeutics | 154.80M |
| Corbus Pharmaceuticals Holdings | 152.53M |
| Sagimet Biosciences | 148.26M |
| Molecular Partners AG | 146.79M |
| Jyong Biotech | 146.11M |
| Nkarta | 142.58M |
| Achieve Life Sciences | 142.15M |